Reducing CRP as important as LDL in primary prevention

7 April 2009 | by Nicola Garrett Print this article Comments Share this article
Reductions in high sensitivity CRP (hsCRP) and low-density lipoprotein (LDL) are equally effective in predicting the efficacy of rosuvastatin, according to findings from the JUPITER trial....

Want to read complete article? Please Sign in or Register.

Recent comments

Most viewed articles this week

Related sites